Home    Back

Tocilizumab (mra-sc)    (DrugBank: Tocilizumab)

1 disease
IDDisease name (Link within this page)Number of trials
40Takayasu arteritis1

40. Takayasu arteritis    [ 22 clinical trials,   46 drugs,   (DrugBank: 20 drugs),   22 drug target genes,   111 drug target pathways]
Searched query = "Takayasu arteritis", "Aortitis syndrome", "Pulseless disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 22 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1JPRN-JapicCTI-142616
02/10/201423/07/2014Phase III Study of MRA-SC in Patients with Takayasu ArteritisA Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase III Study of MRA-SC in Patients with Takayasu Arteritis Takayasu ArteritisIntervention name : tocilizumab (MRA-SC)
INN of the intervention : tocilizumab
Dosage And administration of the intervention : 162mg/W, SC
Control intervention name : Placebo
INN of the control intervention : -
Dosage And administration of the control intervention : Placebo/W, SC		Chugai Pharmaceutical Co., Ltd.NULLcomplete12BOTH34Phase 3Japan